Skip to main content
OpenTrials
Completed

NCT Number: NCT04297514

Effects of Respiratory Rehabilitation by Gender in COPD Patients

Without calling into question the effectiveness of pulmonary rehabilitation in women, the difference in outcome by gender was not established due to insufficient evidence .

Studies demonstrating the effectiveness of pulmonary rehabilitation include a majority of men, which no longer corresponds to the sex ratio of the disease. The impact of gender on pulmonary rehabilitation outcomes was not established due to insufficient evidence.

Completed

Looking for future studies?

Notify Me

Key information

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patient > 18 years old
  • No opposition filed
  • Patient with COPD
  • Completed participation in respiratory rehabilitation program

Exclusion criteria

  • Refusal of participation
  • Patient under tutorship or curatorship
  • No final assessment
  • Patients with sex changes in marital status

Treatment and study plan

Primary outcomes

  1. DYSPNEA-12

    Time frame: Change from baseline Dyspnea-12 score at 4 weeks

    Dyspnea-12 allows to evaluate sensori and emotional dyspnea

Sponsors and collaborators

Lead sponsor

University Hospital, Brest

Other

Registry information

Official study title

Effects of Pulmonary Rehabilitation According to Gender, in COPD Patients

Acronym: REHABGENRE

Important dates

Study start
2020
Primary completion
2020
Study completion
2023
First posted
Mar 5, 2020
Registry last updated
Aug 9, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.